Outreach and inreach organized service screening programs for colorectal cancer

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Chou, Chu Kuang ^a,b   Chen, Sam Li Sheng ^c   Yen, Amy Ming Fang ^c   Chiu, Sherry Yueh Hsia ^d   Fann, Jean Ching Yuan ^e   Chiu, Han Mo ^a,f   Chuang, Shu Lin ^f   Chiang, Tsung Hsien ^a,g   Wu, Ming Shiang ^a   Wu, Chien Yuan ^h   Chia, Shu Li ^h   Lee, Yi Chia ^a,f   Chiou, Shu Ti ^h,i   Chen, Hsiu Hsi ^f  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e KAINAN UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h Ministry of Health and Welfare   (Taiwan)

ⁱ NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST; FECES ANALYSIS; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PUBLIC HEALTH SERVICE; TAIWAN; COLORECTAL NEOPLASMS; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PATIENT REFERRAL; PROCEDURES; PUBLIC RELATIONS;

COLORECTAL NEOPLASMS; COMMUNITY-INSTITUTIONAL RELATIONS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION;

EID: 84969560225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155276     Document Type: Article

References (48)

1. Globocan 2012.Available at: http://globocan.iarc.fr/Default.aspx Accessed Febuary 8, 2015
2. Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, et al. Long-term mortality after screening for colorectal cancer. The New England journal of medicine. 2013; 369(12):1106-14. doi: 10.1056/NEJMoa1300720 PMID: 24047060.
3. Chiang TH, Chuang SL, Chen SL, Chiu HM, Yen AM, Chiu SY, et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology. 2014; 147(6):1317-26. doi: 10.1053/j.gastro.2014.08.043 PMID: 25200099.
4. Chiu HM, Chen SL, Yen AM, Chiu SY, Fann JC, Lee YC, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer. 2015; 121(18):3221-9. doi: 10.1002/cncr.29462 PMID: 25995082.
5. Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut. 2014. doi: 10.1136/gutjnl-2014-307508 PMID: 25179811.
6. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. The New England journal of medicine. 2012; 366(25):2345-57. doi: 10.1056/NEJMoa1114635 PMID: 22612596; PubMed Central PMCID: PMC3641846.
7. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010; 375(9726):1624-33. doi: 10.1016/S0140-6736(10)60551-X PMID: 20430429.
8. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Bmj. 2014; 348:g2467. doi: 10.1136/bmj.g2467 PMID: 24922745; PubMed Central PMCID: PMC3980789.
9. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2009; 7(7):770-5; quiz 11. doi: 10.1016/j.cgh.2008.12.030 PMID: 19268269.
10. Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology. 2014; 146(3):709-17. doi: 10.1053/j.gastro.2013.09.001 PMID: 24012982.
11. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. The New England journal of medicine. 2013; 369(12):1095-105. doi: 10.1056/NEJMoa1301969 PMID: 24047059; PubMed Central PMCID: PMCPMC3840160.
12. Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Archives of internal medicine. 2012; 172(7):575-82. doi: 10.1001/archinternmed.2012.332 PMID: 22493463; PubMed Central PMCID: PMC3360917.
13. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Annals of internal medicine. 2014; 160(3):171. doi: 10.7326/M13-1484 PMID: 24658694; PubMed Central PMCID: PMC4189821.
14. Chiang TH, Lee YC, Tu CH, Chiu HM, Wu MS. Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract. Canadian Medical Association journal. 2011; 183 (13):1474-81. doi: 10.1503/cmaj.101248 PMID: 21810951; PubMed Central PMCID: PMC3176840.
15. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. The New England journal of medicine. 2012; 366(8):697-706. Epub 2012/02/24. doi: 10.1056/NEJMoa1108895 PMID: 22356323.
16. Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. International journal of cancer Journal international du cancer. 2012; 130(12):2961-73. doi: 10.1002/ijc.26310 PMID: 21792895.
17. Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C, et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut. 2012; 61(10):1439-46. doi: 10.1136/gutjnl-2011-300843 PMID: 22156981; PubMed Central PMCID: PMC3437782.
18. Paskett ED, Tatum CM, D'Agostino R Jr., Rushing J, Velez R, Michielutte R, et al. Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) Project. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1999; 8(5):453-9. PMID: 10350442.
19. Boehm JE, Rohan EA, Preissle J, DeGroff A, Glover-Kudon R. Recruiting patients into the CDC's Colorectal Cancer Screening Demonstration Program: strategies and challenges across 5 sites. Cancer. 2013; 119 Suppl 15:2914-25. doi: 10.1002/cncr.28161 PMID: 23868486.
20. Edwards AG, Naik G, Ahmed H, Elwyn GJ, Pickles T, Hood K, et al. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev. 2013; 2:CD001865. doi: 10.1002/14651858.CD001865.pub3 PMID: 23450534.
21. Weinberg DS, Myers RE, Keenan E, Ruth K, Sifri R, Ziring B, et al. Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med. 2014; 161:537-45. doi: 10.7326/M14-0765 PMID: 25329201
22. Altobelli E, Lattanzi A, Paduano R, Varassi G, di Orio F. Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Preventive medicine. 2014; 62:132-41. doi: 10.1016/j.ypmed.2014.02.010 PMID: 24530610.
23. Malila N, Palva T, Malminiemi O, Paimela H, Anttila A, Hakulinen T, et al. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. Journal of medical screening. 2011; 18(1):18-23. doi: 10.1258/jms.2010.010036 PMID: 21536812.
24. Leuraud K, Jezewski-Serra D, Viguier J, Salines E. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Cancer epidemiology. 2013; 37(6):959-67. doi: 10.1016/j.canep.2013.07.008 PMID: 24035240.
25. Ascunce N, Salas D, Zubizarreta R, Almazan R, Ibanez J, Ederra M, et al. Cancer screening in Spain. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2010; 21 Suppl 3:iii43-51. doi: 10.1093/annonc/mdq085 PMID: 20427360.
26. Blom J, Kilpelainen S, Hultcrantz R, Tornberg S. Five-year experience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round. Journal of medical screening. 2014; 21(3):144-50. doi: 10.1177/0969141314545555 PMID: 25070434.
27. Mila N, Garcia M, Binefa G, Borras JM, Espinas JA, Moreno V. [Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008]. Gaceta sanitaria. 2012; 26(3):217-22. doi: 10.1016/j.gaceta.2011.10.020 PMID: 22361637.
28. Centers for Disease C, Prevention. Vital signs: colorectal cancer screening test use - United States, 2012. MMWR Morbidity and mortality weekly report. 2013; 62(44):881-8. PMID: 24196665.
29. Joseph DA, DeGroff AS, Hayes NS, Wong FL, Plescia M. The Colorectal Cancer Control Program: partnering to increase population level screening. Gastrointestinal endoscopy. 2011; 73(3):429-34. doi: 10.1016/j.gie.2010.12.027 PMID: 21353839.
30. Stimpson JP, Pagan JA, Chen LW. Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care. Health affairs. 2012; 31(12):2747-54. doi: 10.1377/hlthaff.2011.1290 PMID: 23213159; PubMed Central PMCID: PMC3541022.
31. Howard J. An Approach to the Secondary Prevention of Cancer. In: Parron DL, Solomon F, Jenkins DL, editors. Behaviors, Health Risks, and Social Disadvantage: Summary of a Conference: National Academy Press; 1982.
32. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system 2010.
33. Sanduleanu S, le Clercq CM, Dekker E, Meijer GA, Rabeneck L, Rutter MD, et al. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut. 2015; 64(8):1257-67. doi: 10.1136/gutjnl-2014-307992 PMID: 25193802.
34. Chiang CJ, Chen YC, Chen CJ, You SL, Lai MS, Taiwan Cancer Registry Task F. Cancer trends in Taiwan. Japanese journal of clinical oncology. 2010; 40(10):897-904. doi: 10.1093/jjco/hyq057 PMID: 20495192.
35. Edge SB, Byrd DR, Carducci MA, et al (Eds.). American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 7th ed. New York: Springer; 2009.
36. Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut. 2007; 56(11):1585-9. doi: 10.1136/gut.2007.122739 PMID: 17591622; PubMed Central PMCID: PMC2095643.
37. Choi KS, Lee HY, Jun JK, Shin A, Park EC. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. Journal of gastroenterology and hepatology. 2012; 27(6):1070-7. doi: 10.1111/j.1440-1746.2011.06944.x PMID: 22004224.
38. Major D, Bryant H, Delaney M, Fekete S, Gentile L, Harrison M, et al. Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs. Current oncology. 2013; 20(5):252-7. doi: 10.3747/co.20.1646 PMID: 24155629; PubMed Central PMCID: PMC3805400.
39. Moss SM, Campbell C, Melia J, Coleman D, Smith S, Parker R, et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut. 2012; 61(1):101-7. doi: 10.1136/gut.2010.236430 PMID: 21561880; PubMed Central PMCID: PMC3230830.
40. Shim JI, Kim Y, Han MA, Lee HY, Choi KS, Jun JK, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer research and treatment: official journal of Korean Cancer Association. 2010; 42(4):191-8. doi: 10.4143/crt.2010.42.4.191 PMID: 21253320; PubMed Central PMCID: PMC3021737.
41. Zorzi M, Fedato C, Grazzini G, Sassoli de' Bianchi P, Naldoni C, Pendenza M, et al. [Screening for colorectal cancer in Italy, 2010 survey]. Epidemiologia e prevenzione. 2012; 36(6 Suppl 1):55-77. PMID: 23293271.
42. Bynum SA, Davis JL, Green BL, Katz RV. Unwillingness to participate in colorectal cancer screening: examining fears, attitudes, and medical mistrust in an ethnically diverse sample of adults 50 years and older. American journal of health promotion. 2012; 26(5):295-300. doi: 10.4278/ajhp.110113-QUAN-20 PMID: 22548424.
43. Kluhsman BC, Lengerich EJ, Fleisher L, Paskett ED, Miller-Halegoua SM, Balshem A, et al. A pilot study for using fecal immunochemical testing to increase colorectal cancer screening in Appalachia, 2008-2009. Preventing chronic disease. 2012; 9:E77. PMID: 22482136; PubMed Central PMCID: PMC3392085.
44. Shelton RC, Jandorf L, Ellison J, Villagra C, DuHamel KN. The influence of sociocultural factors on colonoscopy and FOBT screening adherence among low-income Hispanics. Journal of health care for the poor and underserved. 2011; 22(3):925-44. doi: 10.1353/hpu.2011.0074 PMID: 21841288; PubMed Central PMCID: PMC3635094.
45. McFarland EG, Levin B, Lieberman DA, Pickhardt PJ, Johnson CD, Glick SN, et al. Revised colorectal screening guidelines: joint effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology. Radiology. 2008; 248(3):717-20. doi: 10.1148/radiol.2483080842 PMID: 18710970.
46. Ricardo-Rodrigues I, Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, Jimenez-Trujillo I, Lopez-de-Andres A. Adherence to and predictors of participation in colorectal cancer screening with faecal occult blood testing in Spain, 2009-2011. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation. 2014. doi: 10.1097/CEJ.0000000000000088 PMID: 25304027.
47. ColonCancerCheck,Ontario,Canada.Available at: http://health.gov.on.ca/en/public/programs/coloncancercheck/Accessed Febuary 8, 2015.
48. Colorectal Cancer Control Program. Available at: http://www.cdc.gov/cancer/crccp/Accessed Febuary 8, 2015